Atlas Trials

Panitumumab Combination Study With Rilotumumab or Ganitumab in Wild-type Kirsten Rat Sarcoma Virus Oncogene Homolog (KRAS) Metastatic Colorectal Cancer (mCRC)

Clinical trial NCT00788957 · COMPLETED

Trial details

NCT number
NCT00788957
Sponsor
NantBioScience, Inc.
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Colon CancerColorectal CancerGastrointestinal CancerMetastatic Colorectal CancerRectal Cancer
Start date
2008-10-27
Primary completion
2010-07-23
Enrollment
177

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.